JeNaCell Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
JeNaCell General Information
Description
Developer of bio-technologically derived cellulose designed to manufacture medicines. The company's nano cellulose has a defined shape and controllable structural design that helps clients create innovative and future-oriented products in the fields of medicine, cosmetics, technology and pharmacy, enabling users to protect their skin from chronic wounds with the use of laser treatments and aesthetic dermatology.
Contact Information
Website
www.jenacell.com(Operating Subsidiary)
Corporate Office
- Göschwitzer Stasse 22
- 07745 Jena
- Germany
Corporate Office
- Göschwitzer Stasse 22
- 07745 Jena
- Germany
JeNaCell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 02-Aug-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 07-Jul-2015 | Completed | Generating Revenue | |||
| 3. Seed Round | 11-Oct-2012 | Completed | Startup | |||
| 2. Grant | 20-Jun-2012 | $18.8K | Completed | Startup | ||
| 1. Grant | 15-Mar-2012 | Completed | Startup |
JeNaCell Patents
JeNaCell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025210343-A1 | Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose | Pending | 15-Jan-2024 | ||
| WO-2025153330-A1 | Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose | Inactive | 15-Jan-2024 | ||
| EP-3406728-A1 | Method for producing bacterially synthesized cellulose non-woven | Active | 24-May-2017 | ||
| EP-3406728-B1 | Method for producing bacterially synthesized cellulose non-woven | Active | 24-May-2017 | ||
| EP-3630992-A1 | Method for producing bacterially synthesized cellulose non-woven | Pending | 24-May-2017 | C12P19/04 |
JeNaCell Signals
JeNaCell Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Evonik Venture Capital | Corporate Venture Capital | Minority | ||
| Foundation for Technology, Innovation and Research Thuringia | Corporation | Minority | ||
| Germany's Federal Ministry of Economics and Technology | Government | |||
| Science4Life | Accelerator/Incubator | |||
| Sparkasse Jena | Investment Bank | Minority |
JeNaCell FAQs
-
When was JeNaCell founded?
JeNaCell was founded in 2012.
-
Where is JeNaCell headquartered?
JeNaCell is headquartered in Jena, Germany.
-
What is the size of JeNaCell?
JeNaCell has 12 total employees.
-
What industry is JeNaCell in?
JeNaCell’s primary industry is Medical Supplies.
-
Is JeNaCell a private or public company?
JeNaCell is a Private company.
-
What is JeNaCell’s current revenue?
The current revenue for JeNaCell is .
-
How much funding has JeNaCell raised over time?
JeNaCell has raised $907K.
-
Who are JeNaCell’s investors?
Evonik Venture Capital, Foundation for Technology, Innovation and Research Thuringia, Germany's Federal Ministry of Economics and Technology, Science4Life, and Sparkasse Jena are 5 of 6 investors who have invested in JeNaCell.
-
When was JeNaCell acquired?
JeNaCell was acquired on 02-Aug-2021.
-
Who acquired JeNaCell?
JeNaCell was acquired by Evonik Industries and High-Tech Gründerfonds.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process